Literature DB >> 12663139

Candida albicans mannan-protein conjugate as vaccine candidate.

Slavomír Bystrický1, Ema Paulovicová, Eva Machová.   

Abstract

Mannan-branched polysaccharide with alpha-(1-->6)-linked mannose residues in the linear backbone, is a major virulence and protective factor of yeast Candida albicans. Injected alone does not induce sufficient level of protective antibodies. In this study, we have conjugated mannan to protein carrier by simple one step reaction using 1-cyano-4-dimethylaminopyridinium tetrafluoroborate (CDAP) activation reagent. Prepared mannan conjugate is immunogenic in rabbits and reinjection elicited a booster response with significant increase of serum IgG level. Anti-C. albicans effectiveness of immune serum is clearly demonstrated. Based on these results, the mannan conjugate synthesized by this scheme can be considered as actual vaccine candidate for clinical evaluation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12663139     DOI: 10.1016/s0165-2478(02)00241-9

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  7 in total

1.  Macrophage receptors of polysaccharide isolated from a marine filamentous fungus Phoma herbarum YS4108.

Authors:  Song Chen; Deng-Ke Yin; Wen-Bing Yao; Yi-Dan Wang; Yi-Ran Zhang; Xiang-Dong Gao
Journal:  Acta Pharmacol Sin       Date:  2009-07       Impact factor: 6.150

2.  Vaccination with recombinant N-terminal domain of Als1p improves survival during murine disseminated candidiasis by enhancing cell-mediated, not humoral, immunity.

Authors:  Ashraf S Ibrahim; Brad J Spellberg; Valentina Avenissian; Yue Fu; Scott G Filler; John E Edwards
Journal:  Infect Immun       Date:  2005-02       Impact factor: 3.441

Review 3.  Surface glycans of Candida albicans and other pathogenic fungi: physiological roles, clinical uses, and experimental challenges.

Authors:  James Masuoka
Journal:  Clin Microbiol Rev       Date:  2004-04       Impact factor: 26.132

4.  Dendritic cell interaction with Candida albicans critically depends on N-linked mannan.

Authors:  Alessandra Cambi; Mihai G Netea; Hector M Mora-Montes; Neil A R Gow; Stanleyson V Hato; Douglas W Lowman; Bart-Jan Kullberg; Ruurd Torensma; David L Williams; Carl G Figdor
Journal:  J Biol Chem       Date:  2008-05-15       Impact factor: 5.157

5.  Comparison of protective effect of protein and DNA vaccines hsp90 in murine model of systemic candidiasis.

Authors:  M Raska; J Beláková; N K Wudattu; L Kafková; K Růzicková; M Sebestová; Z Kolár; E Weigl
Journal:  Folia Microbiol (Praha)       Date:  2005       Impact factor: 2.629

Review 6.  Vaccines in the treatment of invasive candidiasis.

Authors:  Xiao-juan Wang; Xue Sui; Lan Yan; Yan Wang; Yong-bing Cao; Yuan-ying Jiang
Journal:  Virulence       Date:  2015-01-06       Impact factor: 5.882

7.  Application of novel analytical ultracentrifuge analysis to solutions of fungal mannans.

Authors:  Richard B Gillis; Gary G Adams; David T M Besong; Eva Machová; Anna Ebringerová; Arthur J Rowe; Stephen E Harding; Trushar R Patel
Journal:  Eur Biophys J       Date:  2016-07-21       Impact factor: 1.733

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.